Introduction
Glutathione S-transferases (GSTs), found in virtually all eukaryotes, are a multigene family of phase-II metabolic enzymes, which catalyze the conjugation of reduced glutathione with a variety of endogenous and exogenous electrophilic compounds, including several potentially toxic carcinogens and chemotherapeutic drugs (Hayes et al., 2005) , thereby reducing the reactivity of the compounds by making them water soluble and favouring their elimination from the body. In mammals eight classes of GSTs, i.e. alpha (GSTA), mu (GSTM), theta (GSTT), Pi (GSTP), zeta (GSTZ), sigma (GSTS), kappa (GSTK), and omega (GSTO) have been identified (Mannervik et al., 1992) , based on sequence homology and substrate specificity. The GSTs have well-established polymorphisms in human populations. The proteins encoded by the different alleles show different abilities to metabolize carcinogens and anticancer agents. It suggests an association between GST polymorphism and the risk for a variety of cancers as well as between said polymorphism and varying responses to cancer treatments. GSTs may also modify susceptibility in certain ethnic groups, showing ethnic dependent polymorphism.
Among all classes of GSTs, GSTM1, GSTT1 and GSTP1 polymorphisms are extensively studied worldwide. The GSTM1 and GSTT1 genes are located on chromosome 1p13.3, and 22q11.2 respectively. Homozygous deletions of GSTM1 and GSTT1 genes are common and result in a complete loss of enzyme activity. The frequencies of GSTM1 null alleles display race and ethnic variations, being highest in Europeans (42-60%) & Asians (41-63%) compared with that of Africans (16-36%) (Cotton et al., 2000; Gao et al., 2010; Hayes et al., 2005; Katoh et al., 2008) . However, the frequency of GSTT1 null genotypes is somewhat less in Europeans (13.31%) compared with that of Africans (14-57%) and in Asians (35-48%) (Cotton et al., 2000; Hayes et al., 2005; Katoh et al., 2008; Sharma et al., 2012) .
The glutathione S-transferase P1 (GSTP1) gene spanning approximately 2.8 kb is located at 11q13 and contains seven exons (Cowell et al., 1988; Kano et al., 1987 ) (Board et al., 1989; Harries et al., 1997; Kano et al., 1987; Watson et al., 1998) . GSTP1 plays a central role in the inactivation of toxic and carcinogenenic electrophiles (Hengstler et al., 1998) . GST enzyme activity is significantly lower among individuals with 105Val allele due to polymorphism at nucleotide 313 in the GSTP1 gene. GST genotypes conferring lower enzyme activity may be of advantage for individuals undergoing chemotherapeutic treatment for neoplastic disease because reduced detoxification potentially enhances effectiveness of cytotoxic drugs. Over the past decade, there has been considerable interest in the biological and clinical consequences of the reported GST polymorphisms. Considering the wide variation in the frequency of GSTP1 alleles in different ethnic populations, we evaluated the distribution of GSTP1 alleles in Delhi population and compared it with the frequency reported in different states of India and other populations worldwide.
Materials and methods

Selection of controls
Peripheral blood from 500 normal controls was collected in vials containing EDTA after receiving their informed consent. The controls selected for the study were either normal volunteers from the Institute, or normal healthy individuals visiting with the patients in various hospitals of Delhi. Information on age, sex, smoking and alcohol habits was obtained. The ethical clearance was obtained from our Institute's ethical committee.
PCR methodology
An ARMS (amplification refractory mutation system) assay, described by (Hemmingsen et al., 2001) was performed to identify four alleles of GSTP1, using two different sets of primers amplifying exon 5 and exon 6. It included a forward Primer upstream of the codon 105 substitution (5′-ACC CCA GGG CTC TAT GGG AA-3′) and two reverse primers; primer 'A' (5′-TCA CAT AGT CAT CCT TGC CGG-3′) (Ala 114 specific) and primer 'B' (5′-TCA CAT AGT CAT CCT TGC CGA-3) (Val 114 specific). Two PCRs were performed for each DNA sample. PCRs were performed in 50 μl reaction volume containing 50-100 ng of genomic DNA, 50 mM KCl, 2.5 mM MgCl 2 , 200 mM Tris (pH 8.4), 200 μM of dNTP each, 1.5 units of Ampli Taq DNA polymerase (Bangalore Genei), forward primer and reverse primers A or B (0.3 μM each). PCR was performed with initial denaturation at 94°C for 5 min, followed by 35 cycles of denaturation at 94°C for 1 min, annealing at 62°C for 1 min, elongation at 72°C for 2 min, and a final extension at 72°C for 7 min. A 998 bp fragment was amplified (Fig. 1a) . PCR products were digested with BsmA1 restriction enzyme and resolved in 3. 
Statistical analysis
The data were tabulated and analysed. The mean ± S.D. were computed for quantitative data. The distribution of the allele and genotype frequencies of GSTP1 was determined by direct counting. Observed frequencies of genotypes in Delhi population were compared with other Indian as well as global populations using Chi square or Fisher's exact test when expected frequencies were small. HardyWeinberg equilibrium was calculated in this population and compared with other global populations. P value b 0.05 was considered significant.
Results
A total of 500 healthy individuals, 274 (54.8%) males: 226 (45.2% females participated in this study. The participants had a median age of 32 years, ranging from 18 to 57 years. The mean age of males and females was 33.1 ± 6.7and 32.6 ± 6.8 respectively and the age distribution was not different between both the sexes (p = 0.41). Of 500 individuals, 97 (19.4%) were smokers, 126 (26.5%) were alcoholics and 43(8.6%) were betel nut/tobacco chewers. Among the smokers, 85 (87.6%) were males and 12 (12.4%) were females. Table 1 represents genotype and allele frequencies of GSTP1 gene polymorphisms in Delhi population. All individuals were analyzed for GSTP1 polymorphisms and most of them were having GSTP1AA (44.6%), GSTP1 AB (33.8%) and GSTP1 AC (8.2%) genotypes (Table 1 ). The number of individuals with other genotypes was very less. Frequencies of four alleles of GSTP1 namely GSTP1*A, GSTP1*B, GSTP1*C and GSTP1*D were 0.663, 0.248, 0.069 and 0.020 respectively (Table 1) . No significant difference in the frequencies of the GSTP1 gene between males and females, smokers and non-smokers, alcoholics and nonalcoholics, tobacco chewers and non-chewers (p N 0.05) was observed (data not shown).The frequency distribution of GSTP1 alleles in Indian and global populations is tabulated in Tables 2, 3 & 4. There are only few studies where the frequency of GSTP1*A, GSTP1*B, GSTP1*C and GSTP1*D was calculated (Table 2) . In all these studies the differences in frequencies were not significant except in one study from Egypt, where the frequencies were reversed from that of our observation and the differences were highly significant (p b 0.001). In Egyptians, both GSTP1*C and GSTP1*D alleles were not observed. GSTP1*D was absent in two Italian studies and rare in other studies also (Table 2) .
In India the frequency of GSTP1 Ile105/Ile105 allele was almost similar throughout India (p = 0.05) with a few exceptions Bose and Bathri, 2012; Dunna et al., 2012; Konwar et al., 2010; Qadri et al., 2011; Vettriselvi et al., 2006; Vijayalakshmi et al., 2005) , where the frequency was high. In one of the studies from Jammu & Kashmir (Qadri et al., 2011 ) the frequency of GSTP1 Ile105/Ile105 allele was so high as compared with the present study, that after including this single study the differences became significant (p b 0.001) ( Table 3 ). The frequencies of GSTP1 genotypes did not achieve Hardy-Weinberg equilibrium in the clubbed data of North Indians (p b 0.001), South Indians (p b 0.002) and Central Indians (p b 0.01) ( Table 3) .
We have calculated and compared the frequency of GSTP1 alleles in four main world populations namely Africans, Europeans, Asians and Indians, with the present study ( Table 4) 
Discussion
GSTs are involved in the biotransformation of exogenous substances, including mutagens, carcinogens, and other poisonous chemicals, and play a crucial role in the detoxification process, thereby protecting cells from these compounds . Epidemiological studies have suggested that individuals differing in the expression of allelic variants of GSTP1 gene differ in susceptibility to various chemical carcinogens (Nakajima and Aoyama, 2000) . In the present study we have examined the GSTP1 Ile/Val polymorphism by ARMS assay to know the base data of GSTP1*A, GSTP1*B, GSTP1*C and GSTP1*D alleles in normal Delhi population. The information on frequencies of these four alleles was available in a few studies (Table 2) . They have also observed almost similar results and the differences in frequencies were not statistically significant when compared with the present study (Ballerini et al., 2003; Bernardini et al., 2005; Hemmingsen et al., 2001 ). However in one study from Egypt, statistically significant differences emerged. The reason for this variation is not known, may be the number of individuals was very less in that study (Abdel-Alim et al., 2007) . The frequency distribution of GSTP1 alleles observed in the present study is almost similar throughout India except for Jammu & Kashmir, Lucknow, Central India and South India, thus suggesting a distinct difference among the Indian population. The reason for this diversity in the Indian population is believed to be because of different socio-cultural traditions, lifestyles and exposures.
Distinct ethnic differences also exist in the frequency of GSTP1 Ile/Val polymorphism. The range of Ile allele frequency was 0.47-0.86 in Africans, 0.63-0.76 in Europeans, 0.67-0.92 in Asians and 0.59-0.84 in Indians (from data mentioned in Table 4 ). The frequency distribution of mutant allele Val105/Val105 was most frequent among South African Xhosas (0.53) and African American (0.51) and least frequent among Tanzanians (0.14) (Adams et al., 2003; Dandara et al., 2002; Millikan et al., 2000) . The range of Val105/ Val105 allele was 0.14-0.53 in Africans, 0.23-0.37 in Caucasians, 0.08-0.33 in Asians and 0.16-0.41 in Konwar et al., 2010; Mishra et al., 2004; Qadri et al., 2011; Soya et al., 2005; Srivastava et al., 2005) (50.6%) (45.0%) (4.40%)
South Indians 1448 720 635 93 0.717 0.283 P = 0.11 (Dunna et al., 2012; Lakkakula et al., 2013; Samson et al., 2007; Soya et al., 2005; Vettriselvi et al., 2006; Vijayalakshmi et al., 2005) (Adams et al., 2003; Burim et al., 2004; Dandara et al., 2002; Masimirembwa et al., 1998; Millikan et al., 2000; Rossini et al., 2002; Watson et al., 1998 (Agalliu et al., 2006; Andonova et al., 2010; Fontana et al., 2009; Gsur et al., 2001; Harries et al., 1997; Jerónimo et al., 2002; Kote-Jarai et al., 2001; Loktionov et al., 2001; Millikan et al., 2000; Mitrunen et al., 2001; Shepard et al., 2000; Sørensen et al., 2007; Soya et al., 2005; Steinhoff et al., 2000; Vlaykova et al., 2012; Watson et al., 1998; Welfare et al., 1999 Ansari et al., 2010; Aynacioglu et al., 2004; Cheng-Gang et al., 2012; Cho et al., 2005; Chonlada et al., 2009; Kawai et al., 2005; Kiran et al., 2010; Kiyohara et al., 2003; Kunak et al., 2012; Lee et al., 2005; Soya et al., 2005; Watson et al., 1998) Bid et al., 2010; Bose and Bathri, 2012; Dunna et al., 2012; Konwar et al., 2010; Mishra et al., 2004; Qadri et al., 2011; Samson et al., 2007; Soya et al., 2005 Soya et al., , 2007 Srivastava et al., 2005; Vettriselvi et al., 2006; Vijayalakshmi et al., 2005 Indians (from data mentioned in Table 4 ). GSTP1 105Val is less frequent in Asians as compared to Caucasians. A complete absence of the mutant homozygous Val105/Val105 genotype was also reported in one of the studies from Japan (Kiyohara et al., 2003) . Observation from the present study of the genotype distribution of GSTP1 Ile/Ile and Ile/Val reveals that it varies significantly from Asians (p b 0.0001) but not from Africans, Europeans and Indians. Similar results were also observed in other studies (Mishra et al., 2004; Polimanti et al., 2011; Tan et al., 2000) . The GSTP1 Val/Val genotype is uncommon and exists in 5% of Caucasians (Garte et al., 2001 ). This form of the GSTP1 enzyme has been reported to be 2-3 times less stable than the Ile105 form (Johansson et al., 1998) and possibly associated with a higher level of DNA adducts (Ryberg et al., 1997) . Individuals with GSTP1 Val/Val genotype had significantly better survival in hepatocellular carcinoma patients (Cheng-Gang et al., 2012) , but this genotype is associated with worse outcome in basal cell carcinoma (Ramachamdran et al., 2000) and breast cancer (Zhang et al., 2011) . In a meta analysis it has been reported that individuals with GSTP1 Ile105/Val 105 genotype increase susceptibility to breast cancer in Asian population (Lu et al., 2011) , while a good response and light toxicity were also observed in breast cancer patients carrying GSTP1 Ile105/Val 105 or Ile 105/Ile105 genotype (Zhang et al., 2011) . Individuals with homozygous genotypes of GSTP1 Ile/Ile were reported to have the lowest risk of prostate cancer (Kote-Jarai et al., 2001) , and this genotype is found to be protective in rheumatoid arthritis (Mattey et al., 1999) and basal cell carcinoma (Ramachamdran et al., 2000) . An over expression of GSTP1 enzyme in individuals with Ile/Ile genotype causes resistance to drugs like cisplatin in oral and maxillofacial carcinoma (Townsend and Tew, 2003; Xu et al., 2002) . Thus GST polymorphism studies will provide a clue to the identification of responders to cancer therapy with certain chemotherapeutic drugs.
GSTP1 associated risk is probably disease-dependent, and may reflect differences in relevant substrates. Individuals with different combinations of GST alleles would also help in studying the effect of various carcinogens in different populations having various exposures and giving personalised treatment in case of cancer. Understanding the contribution of GST gene polymorphisms and their interactions with other relevant factors may improve screening diagnostic assays for various cancers. Thus, our results signify the impact of ethnicity and provide a basis for future epidemiological and clinical studies.
